Farifax, VA – May 16, 2017 – eKare Inc., a medtech company based in the metropolitan D.C. area, announced the establishment of its Scientific Advisory Board, comprised of some of the country’s foremost wound care experts. eKare provides advanced wound imaging technology, including 3D wound measurement and tissue classification, at the point of care on mobile devices.
Backed by expertise in wound care, dermatology, podiatry, vascular, and plastic surgery, eKare’s new Scientific Advisory Board will play an important role in steering the strategic direction of eKare’s wound imaging and analytics platform.
“We are very privileged to be joined by these distinguished scientists and clinicians.” says Dr. Kyle Wu, CMO of eKare Inc. “They are some of the best minds in the field. Expertise of such caliber is invaluable as we look to turn data into actionable insights through analytics.”
“eKare’s technology is addressing a critical but unfulfilled need in wound care,” remarks Dr. Paul Kim, a member of the advisory board, “It’s truly exciting to be part of an organization that’s helping to reshape a field of medicine.”
The eKare Scientific Advisory Board Members include:
• Paul Kim, DPM, Medstar Georgetown University Hospital, Washington, D.C.
• Robert S. Kirsner, M.D., Ph.D., University of Miami Miller School of Medicine, Miami, FL
• John C. Lantis, M.D., Mount Sinai School of Medicine, New York, NY
• Larry Lavery, DPM, UT Southwestern Medical Center, Dallas, TX
Phone: +1 (844) 443-5273
eKare Inc. is dedicated to the design and development of wound assessment solutions, including 3D wound dimensions and tissue classification capabilities, using the latest computer-vision and mobile technology. eKare’s innovative technology is creating new possibilities in how we deliver wound care across the healthcare continuum, from inpatient hospital and skilled nursing facilities to ambulatory clinics and telemedicine. eKare’s mission is to advance the science and delivery of wound care by leveraging mobile and sensor technologies to connect patients, providers, and industry.
The views and opinions expressed in this blog are solely those of the author, and do not represent the views of WoundSource, Kestrel Health Information, Inc., its affiliates, or subsidiary companies.